Abu Dhabi Ports aims to play a vital role in the global fight against Covid-19 by developing enhanced logistics capabilities for the storage and distribution of more than 70 million vaccine doses. This follows the launch of the Hope Consortium, a UAE-based public-private partnership, of which Abu Dhabi Ports is a member, that will facilitate the distribution of vaccines across the world.
As part of its commitment to this immunisation drive, Abu Dhabi Ports has dedicated a 19,000 m2 temperature-controlled warehouse facility in Khalifa Industrial Zone Abu Dhabi (KIZAD), which already houses more than 1
million vials of the vaccine. The facility has the capability to store vaccines and other pharmaceutical products at a range of +2 to 8 degC, as well as the more extreme range of -80 degC required by some vaccines. The warehouse is equipped with temperature and humidity systems monitored digitally via a control dashboard.
The Hope Consortium is being led by the Department of Health – Abu Dhabi. As well as Abu Dhabi Ports, it includes Etihad Cargo, Rafed, and Switzerland’s SkyCell.
Robert Sutton, Head of Logistics Cluster, Abu Dhabi Ports, said: “Abu Dhabi Ports’ ability in expanding capacity to receive and store clinical, pharmaceutical and life science materials at moderate and extreme temperature ranges is a testament to our commitment to offer world-class logistics solutions. Our Department of Health-licenced facility fully integrates the movement of cargo with state-of-the-art temperature, humidity, and refrigeration-controlled technology. Abu Dhabi Ports, through our highly-advanced infrastructure and multimodal connectivity, is ready and able to meet the challenges of distributing sensitive pharmaceuticals quickly across the supply chain.”